Continued nationwide drug shortages and supply chain disruptions have prompted South Dakota Gov. Kristi Noem to call on the state department of health to make an expansion of the state's medical cache, according to a July 12 news release. 

Less than a week after Eisai secured a full approval for Leqembi — the first Alzheimer's drug to achieve full approval — the drugmaker's CEO announced his plan to retire by the end of July. 

CVS Health's pharmacy benefit manager, CVS Caremark, teamed up with GoodRx to broaden access to cheaper drug options, the organizations said July 12. 

System errors unexpectedly disrupted CVS Caremark's prescription processing July 11, leaving patients frustrated and some without access to medication, The Wall Street Journal reported July 10. 

There's a national shortage of dimercaprol, the main therapy for lead poisoning, The Wall Street Journal reported July 11. About four months ago, the country's only domestic supplier of the product closed its doors.

More than $8.4 billion in expected annual contract savings for the hospital safety-net is at risk, according to a July 11 report from 340B Health.

ADC Therapeutics is voluntarily pausing enrollment in a phase 2 study evaluating two drugs for lymphoma after seven patients died and five experienced worsening health during treatment. 

The Biden administration released a plan July 11 to clamp down on xylazine-fentanyl mixtures, a drug combination that it labeled an emerging threat in April and that has mystified clinicians.

When an illness paralyzed Renee Tyree, PharmD, at 19 years old, she was told she wouldn't become a doctor after she became a wheelchair user. 

The American Society of Health-System Pharmacists has honored six hospitals with its certificate of excellence in medication use safety and pharmacy practice.

The FDA is allowing 10 more lots of cisplatin from a China-based pharmaceutical company to be imported to the U.S. to ease the ongoing cancer drug shortage, Bloomberg reported July 10. The additional lots are set to arrive next week. 

Nearly six in 10 children who take medicine for an out-of-hospital emergency are given the incorrect dosage, according to a study published July 10 in Pediatrics. 

Heartland Healthcare Services, a pharmacy company owned by CVS Health and HCR-ManorCare, plans to close two facilities and lay off 195 workers in Ohio and Maryland, according to WARN filings. 

A recent revision to a Utah law allows pharmacists in the state to prescribe birth control to patients without a physician-issued order. And Salt Lake City-based Intermountain Health wasted no time implementing a new program to carry this out. 

The U.S. is low on about 140 drugs, including critical cancer therapies and local anesthetics, according to the FDA's drug shortage database. 

In the first quarter of 2023, 301 "basic hospital drugs" were in short supply across the United States, causing treatment delays and increasing the chance of medication errors, according to a July 7 American Hospital Association letter to members of Congress.

Warren, N.J.-based Cipla USA, a subsidiary of India-based pharmaceutical company Cipla, recalled six batches of albuterol sulfate inhalation aerosol solutions after one complaint of the product leaking. 

Kealakekua, Hawaii-based Kona Community Hospital hosted a groundbreaking for its pharmacy expansion project, which cost $2.3 million and includes a clean room suite, Big Island Now reported July 6. 

The FDA granted full approval to Leqembi (lecanemab) July 6, six months after handing Eisai and Biogen's Alzheimer's drug an accelerated approval. 

Keck Medicine of USC, based in Los Angeles, promoted Krist Azizian, PharmD, to fill the systemwide role of chief pharmacy officer.